1. Advanced Ovarian Cancer Trials Group (1991) Chemotherapy in advanced ovarian cancer: an overview of randomized clinical tirals. BMJ 303: 884–893
2. Alberts DS, Green S, Hannigan EV, O’Toole R et al. (1992) Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol 10: 706–717
3. Alberts DS, Liu PY, Hannigan EV, O’Toole T et al. (1995) Phase III study of i.p. cisplatin/cyclophosphamid versus i.v. cisplatin/i.v. cyclophosphamide in the treatment of nonmeasurable optimal stage III ovarian cancer. Proc IGCS Philadelphia 1995 (abstract)
4. Anderson H, Wagstaff J, Crowther D et al. (1988) Cooperative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin
5. Averette HE, Hoskins W, Nguyen HN et al. (1993) National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons. Cancer 71: 1629–1638